CS
Catherine Schulte Baird Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
27
Avg Return
Past Year
Past Year
2.8%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
81.5%
Neutral
18.5%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Health Information Services
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Maintained
| $28 |
41%
upside
| 2 | -1.7% |
0
%
| 27 Feb ‘26 6 days ago |
|
|
|
Outperform
Maintained
| $82 |
52%
upside
| 2 | -21% |
0
%
| 20 Feb ‘26 12 days ago |
|
|
|
Outperform
Initiated
| $59 |
15%
upside
| 1 | -1.3% |
0
%
| 17 Feb ‘26 16 days ago |
|
|
|
Outperform
Initiated
| $120 |
29%
upside
| 1 | -11% |
0
%
| 17 Feb ‘26 16 days ago |
|
|
|
Outperform
Maintained
| $165 |
37%
upside
| 3 | +5.6% |
0
%
| 25 Nov ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $88 |
15%
downside
| 2 | +48% |
0
%
| 4 Nov ‘25 4 months ago |
|
|
|
Outperform
Maintained
| $17 |
97%
upside
| 4 | -4.5% |
0
%
| 24 Oct ‘25 4 months ago |
|
|
|
Neutral
Maintained
| $1,230 |
4%
downside
| 3 | – |
–
| 4 Aug ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $567 |
11%
upside
| 3 | +6% |
0
%
| 24 Jul ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $229 |
12%
upside
| 4 | +2% |
0
%
| 23 Jul ‘25 7 months ago |
|
|
|
Neutral
Maintained
| $2 |
48%
downside
| 1 | -60% |
–
| 13 May ‘25 9 months ago |
|
|
|
Neutral
Maintained
| $43 |
8%
downside
| 1 | – |
–
| 21 Apr ‘25 10 months ago |
|